Literature DB >> 7025890

Investigation of the nature of enzyme--coenzyme interactions in binary and ternary complexes of liver alcohol dehydrogenase with coenzymes, coenzyme analogues, and substrate analogues by ultraviolet absorption and phosphorescence spectroscopy.

S Subramanian, J B Ross, P D Ross, L Brand.   

Abstract

The difference spectra of binary and ternary complexes of horse liver alcohol dehydrogenase with oxidized and reduced nicotinamide adenine dinucleotides, nicotinamide 1,N6-ethenoadenine dinucleotide, and adenosine diphosphate ribose along with a number of substrate analogues have been measured. These spectra bear a very close resemblance to those obtained by perturbation of the coenzyme(s) and their analogues by acid, NaCl, dioxane, or tert-butyl alcohol. It is inferred that the coenzymes experience a combination of ionic and nonpolar environments at the adenine binding site of the enzyme. This is borne out by published X-ray crystallographic results. The phosphorescence spectra do not indicate the presence of ionized tyrosine in ternary complexes invovling enzyme, coenzyme, and substrate analogues. The ultraviolet spectra can be explained as arising from the perturbation of the coenzyme chromophores upon binding to the enzyme without having to invoke tyrosine ionization.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7025890     DOI: 10.1021/bi00517a022

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  2 in total

1.  Carrier-Free, Dual-Functional Nanorods Via Self-Assembly Of Pure Drug Molecules For Synergistic Chemo-Photodynamic Therapy.

Authors:  Yuping Zhao; Yanna Zhao; Qisan Ma; Bin Sun; Qingpeng Wang; Zhuang Ding; Huaizhen Zhang; Xiuling Chu; Min Liu; Zhengping Wang; Jun Han
Journal:  Int J Nanomedicine       Date:  2019-11-05

2.  The toxic effects of alizarin red S on catalase at the molecular level.

Authors:  Shimeng Hu; Dong Yuan; Yang Liu; Lining Zhao; Hongli Guo; Qigui Niu; Wansong Zong; Rutao Liu
Journal:  RSC Adv       Date:  2019-10-17       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.